|
|
Article: Zoloft was the leading SSRI/SNRI in 2004.(VITAL SIGNS)(selective serotonin reuptake inhibitor/selective norepinephrine reuptake inhibitor)(Brief Article)
- Article from:
- Clinical Psychiatry News
- Article date:
- May 1, 2005
CopyrightCOPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Zoloft Was the Leading SSRI/SNRI in 2004
Zoloft 28%
Effexor XR 23%
Lexapro 16%
Celexa 9%
Paxil CR 8%
All Others 16%
Note: Based on share of total wholesale ...
Related newspaper, magazine, and journal articles:
|
|
Article: Focus on citalopram: A selective serotonin reuptake ...
Formulary;
August 1, 1998 ;
700+ words
...A selective serotonin reuptake inhibitor for the treatment of depression Citalopram is a selective serotonin reuptake inhibitor (SSRI) approved by the FDA for the treatment of major depression. Pharmacologically, it has higher serotonin selectivity ...
|
|